Leidos Holdings, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$1.11B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: LDOS stock price vs WY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WY's multiple
Needs WY P/E.
Implied fair value · at LDOS's multiple
Needs LDOS P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Leidos Holdings, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
WEYERHAEUSER COMPANY · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTERNATIONAL BUSINESS MACHINES CORP
LDOS vs IBM
Accenture plc
LDOS vs ACN
LOCKHEED MARTIN CORP
LDOS vs LMT
NORTHROP GRUMMAN CORP /DE/
LDOS vs NOC
GENERAL DYNAMICS CORP
LDOS vs GD
ZEBRA TECHNOLOGIES CORP
LDOS vs ZBRA
RAYONIER INC
LDOS vs RYN
POTLATCHDELTIC CORP
LDOS vs PCH
INTERNATIONAL PAPER CO /NEW/
LDOS vs IP
UFP INDUSTRIES INC
LDOS vs UFPI
VORNADO REALTY TRUST
LDOS vs VNO
COSTAR GROUP, INC.
LDOS vs CSGP
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe LDOS can sustain its 3.1% revenue growth and 24.9% ROIC while maintaining current margins, then the stock looks attractive to own because it trades well below WY on P/E, P/S, and EV/EBITDA despite stronger fundamentals and a cleaner net leverage profile.
LDOS trades at a steep valuation discount to WY on earnings, sales, and cash-flow proxies despite stronger operating performance. The 9.4x P/E for LDOS versus 52.5x for WY, along with 0.8x P/S versus 2.5x, suggests the market is assigning WY a much richer multiple despite weaker fundamentals.
Supporting Metrics